Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 35.88 % |
3 Month Return | + 16.37 % |
1 Year Return | + 39.12 % |
Market Stats | |
Previous Close | ₹335.15 |
Open | ₹333.85 |
Volume | 23.95K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹688.79Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹688.79 Cr |
P/B Ratio | 7.09 |
EPS | 2.76 |
Dividend Yield | 0 |
Sector | Miscellaneous |
ROE | 14.07 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹688.79 Cr | 196.51% | 0.60 | ₹5 Cr | ₹50 Cr | |
NA | ₹27.56 Cr | 219.47% | 0.55 | NA | ₹16 Cr | |
NA | ₹529.08 Cr | 183.7% | 0.54 | ₹14 Cr | ₹100 Cr | |
NA | ₹84.64 Cr | 53.91% | 0.73 | -₹2 Cr | ₹90 Cr | |
NA | ₹883.42 Cr | 9.37% | 0.69 | ₹49 Cr | ₹1,375 Cr |
Organisation | Indo US Bio-Tech Ltd |
Headquarters | |
Industry | Miscellaneous |
E-voting on shares | Click here to vote |
Key events for Indo US Bio-Tech Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
In the last 3 years, INDOUS has outperformed top 5 stocks with highest market-cap in Biotechnology & Medical Research
Price Rise
In the last 1 month, INDOUS stock has moved up by 36.5%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 70.17% of holdings in Sep 2024 quarter
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 29.83% of holdings in Sep 2024 quarter
Against Peers
In the last 1 year, Vimta Labs Ltd has given 147.3% return, outperforming this stock by 109.7%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 70.17% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 29.83% | 0.00 | |
Others | 0% | 0.00 |
Indo US Bio-Tech Ltd’s net profit jumped 161.08% since last year same period to ₹4.36Cr in the Q2 2024-2025. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated 37.54% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending September 2024, Indo US Bio-Tech Ltd has declared dividend of ₹0.25 - translating a dividend yield of 0.08%.
Read More about DividendsBearish
Neutral
Bullish
Indo US Bio-Tech Ltd is currently in a Neutral trading position according to technical analysis indicators.
Indo US Bio-Tech Ltd (INDOUS) share price today is ₹313.05
Indo US Bio-Tech Ltd is listed on NSE
Indo US Bio-Tech Ltd is listed on BSE
Today’s traded volume of Indo US Bio-Tech Ltd(INDOUS) is 23.95K.
Today’s market capitalisation of Indo US Bio-Tech Ltd(INDOUS) is ₹688.79Cr.
Indo US Bio-Tech Ltd(INDOUS | Price |
---|---|
52 Week High | ₹388.4 |
52 Week Low | ₹222 |
Indo US Bio-Tech Ltd(INDOUS) share price is ₹313.05. It is down -19.40% from its 52 Week High price of ₹388.4
Indo US Bio-Tech Ltd(INDOUS) share price is ₹313.05. It is up 41.01% from its 52 Week Low price of ₹222
Indo US Bio-Tech Ltd(INDOUS | Returns |
---|---|
1 Day Returns | -22.1% |
1 Month Returns | 35.88% |
3 Month Returns | 16.37% |
1 Year Returns | 39.12% |